Explore

Rapid Read Rapid Read
Alloy Health Expands Menopause Weight Care Program with New Offerings

Alloy Health Expands Menopause Weight Care Program with New Offerings

Alloy Health, a virtual healthcare platform focused on midlife women's health, is expanding its weight care program to include micro-dosing and the Wegovy pill. These additions aim to provide personalized dosing options and an oral GLP-1 alternative for women who prefer not to use injections. The program, which launched last year, addresses weight gain during menopause, a common issue linked to hormonal changes that can lead to metabolic problems. Alloy's approach combines hormonal expertise with personalized care plans, emphasizing the importance of nutrition, exercise, and sleep. The company also offers compounded medications for those who cannot tolerate standard doses, ensuring a tailored approach to each patient's needs.
Reuters Reuters
Patients scramble to find estrogen patches as shortage worsens after US FDA champions use

Patients scramble to find estrogen patches as shortage worsens after US FDA champions use

By Mrinalika Roy and Sriparna Roy April 9 (Reuters) - A surge in demand since last year for estrogen patches to ease menopause symptoms has strained supplies and led to shortages, sparking a scramble for medicines that industry sources say could last up to three years.
Trendline Trendline
Sanofi's Lunsekimig Shows Mixed Results in Phase 2 Trials for Respiratory and Dermatology Conditions

Sanofi's Lunsekimig Shows Mixed Results in Phase 2 Trials for Respiratory and Dermatology Conditions

Sanofi's Lunsekimig Shows Mixed Results in Phase 2 Trials for Respiratory and Dermatology Conditions
Trendline Trendline
Biocon Launches Denosumab Biosimilars in U.S. to Address Osteoporosis and Cancer-Related Bone Issues

Biocon Launches Denosumab Biosimilars in U.S. to Address Osteoporosis and Cancer-Related Bone Issues

Biocon Launches Denosumab Biosimilars in U.S. to Address Osteoporosis and Cancer-Related Bone Issues
Trendline Trendline
Alloy Health Expands Menopause Weight Care Program with New Offerings

Alloy Health Expands Menopause Weight Care Program with New Offerings

Alloy Health Expands Menopause Weight Care Program with New Offerings
Rapid Read Rapid Read
Abbvie and Genentech Join TrumpRx to Offer Discounted Medications

Abbvie and Genentech Join TrumpRx to Offer Discounted Medications

Abbvie and Genentech have become the latest pharmaceutical companies to join TrumpRx, a White House initiative aimed at reducing prescription drug prices. These companies will offer popular medications at significantly reduced prices on the TrumpRx platform. Abbvie will provide Humira, used for conditions like rheumatoid arthritis, at an 86% discount, while Genentech will offer Xofluza, a flu treatment, at a reduced cost. The Trump administration is working to formalize these discount deals under the 'Great Healthcare Plan,' although Congress has yet to consider the proposal. The initiative primarily benefits uninsured individuals or those whose insurance does not cover these medications.
Rapid Read Rapid Read
Ohio Governor Race: Acton Proposes Affordability Plan Amid Funding Concerns

Ohio Governor Race: Acton Proposes Affordability Plan Amid Funding Concerns

Democratic gubernatorial candidate Amy Acton has unveiled an affordability plan aimed at reducing costs for Ohioans. The plan includes child tax credits ranging from $500 to $1,000 annually, a refundable tax credit for lower-income families, and measures to reduce prescription drug costs. Acton also proposes increased transparency in insurance and healthcare pricing, and efforts to cut red tape for Medicaid enrollment. However, Acton has not provided specific details on how these initiatives will be funded, stating that collaboration with the private sector will be key. Her proposals have faced criticism from Republicans, who argue that the plan could lead to increased state spending and higher taxes.
Trendline Trendline
Evommune to Highlight MRGPRX2 Inhibition Potential in Migraine Treatment

Evommune to Highlight MRGPRX2 Inhibition Potential in Migraine Treatment

Evommune to Highlight MRGPRX2 Inhibition Potential in Migraine Treatment
Trendline Trendline
Evommune to Explore MRGPRX2 Inhibition for Migraine Treatment

Evommune to Explore MRGPRX2 Inhibition for Migraine Treatment

Evommune to Explore MRGPRX2 Inhibition for Migraine Treatment
Trendline Trendline
Beyond Yoga's Workout Top Gains Popularity for Comfort and Versatility

Beyond Yoga's Workout Top Gains Popularity for Comfort and Versatility

Beyond Yoga's Workout Top Gains Popularity for Comfort and Versatility
Rapid Read Rapid Read
Legion Health's AI System Approved to Prescribe Psychiatric Medication in Utah

Legion Health's AI System Approved to Prescribe Psychiatric Medication in Utah

Legion Health, a San Francisco-based startup, has received approval to use its AI application to prescribe psychiatric medications in Utah. The AI system is designed to renew prescriptions for specific medications such as fluoxetine (Prozac) and sertraline (Zoloft), which are used to treat anxiety and depression. The system is restricted to renewing prescriptions that were initially prescribed by a human psychiatrist, and it is only applicable to patients who are stable and have not been hospitalized for psychiatric conditions in the past year. Despite these limitations, experts express concerns about the potential for over-treatment and the system's ability to accurately assess patient needs. The AI system is part of a broader effort to address mental health care shortages in Utah, with the company planning to expand the service nationwide by the end of the year.
Trendline Trendline
Amgen's New Tepezza Formulation Aims to Boost Sales Amidst Market Challenges

Amgen's New Tepezza Formulation Aims to Boost Sales Amidst Market Challenges

Amgen's New Tepezza Formulation Aims to Boost Sales Amidst Market Challenges